Search clinical trials for: Ciclosporine A

Total 11204 results

ISDIN

Completed

Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque Test

Psoriasis

Germany
Genzyme, a Sanofi Company
BioMarin/Genzyme LLC

Completed

Immune Tolerance Study With Aldurazyme® (Laronidase)

Mucopolysaccharidosis I

Brazil, Russian Federation
Baylor College of Medicine
Allergan

Terminated

The Effects of Cyclosporin A in a Low Humidity Environment, on the Ocular Surface (CsA)

Dry Eye

United States
Peking University People's Hospital

Unknown

Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome (CTRIPS)

Sjogren's Syndrome

China
West China Hospital

Recruiting

Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy

Hepatitis, Autoimmune | Immunosuppression | Primary Biliary Cholangitis

China
University Hospital Tuebingen

Completed

Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB) (INCYTOB)

Panuveitis | Posterior Uveitis | Retinal Vasculitis | Behcet's Disease

Germany
Peking Union Medical College Hospital

Not yet recruiting

CsA+ATG+AVA vs. CsA+AVA for the Treatment of Newly-diagnosed SAA in the Elderly

Aplastic Anemia

China
Assistance Publique - Hôpitaux de Paris

Completed

Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT (ATG-CyGVHD)

Graft vs Host Disease

France
Allergan

Completed

Study of Cyclosporine in Post-LASIK Patients

Laser In Situ Keratomileusis

United States
Hospital Universitario Dr. Jose E. Gonzalez

Completed

Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCT (HSCT)

Graft-Versus-Host Disease

Mexico
Chulalongkorn University
Allergan

Unknown

Comparison of Efficacy, Safety and Anti-Inflammatory Effect Between Topical 0.05%Cyclosporine A Emulsion and REFRESH® in Patients With Moderate to Severe Dry Eyes

Dry Eye

Thailand
Farwaniya Hospital

Recruiting

Clinical Outcomes of Cyclosporine Eye Drops in Management of Herpetic Keratitis

Outcomes of Cyclosporine Eye Drops in Herpetic Keratitis

Kuwait
Central South University

Unknown

The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients

Kidney Transplantation

China
Shanghai General Hospital, Shanghai Jiao Tong University...

Unknown

Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients

Acute Myeloid Leukemia | Disorder Related to Bone Marrow Transplantation

China
Penang Hospital, Malaysia

Completed

Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients

End Stage Renal Failure

Malaysia
Panacea Biotec Ltd

Completed

Bioequivalence Study of Cyclosporine 100mg Capsule Under Fasting Condition

Healthy Volunteers

India
Farwaniya Hospital

Completed

Topical Cyclosporin A 0.05% Eye Drops for Management of Symptomatic Acquired Punctal Stenosis. A Prospective, Controlled Clinical Study.

Management of Punctal Stenosis

Kuwait
Sun Yat-sen University

Unknown

A Controlled Study of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous Nephropathy

Proteinuria | Idiopathic Membranous Nephropathy | Spontaneous Remission | Steroid Nephropathy | Cyclosporin Overdose

China
Novartis Pharmaceuticals

Completed

Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 Levels

Heart and Lung Transplant

Switzerland
Massachusetts Eye and Ear Infirmary

Terminated

The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry Eye

Dry Eye

United States
University Hospital Muenster
Hoffmann-La Roche

Unknown

CYA Versus MMF for Treatment of Moderate-Severe Psoriasis.

Psoriasis

Germany
Novartis Pharmaceuticals

Completed

A Study to Evaluate the Efficiency of Intravenously Administered Cyclosporine in de Novo Liver Transplant Recipients

Liver Transplantation

Germany
Panacea Biotec Ltd

Completed

Bioequivalence Study of Cyclosporine 100mg Capsule Under Fed Condition

Healthy Volunteers

India
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer

Leukemia | Anemia | Thrombocytopenia | Neutropenia

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma

Refractory Multiple Myeloma

United States, Italy
Fred Hutchinson Cancer Center
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow Transplant

Aplastic Anemia

United States
SCAI Therapeutics

Completed

Clinical Trial to Evaluate the Safety and Efficacy of SCAI-001 Compared to Restasis

Dry Eye Syndromes

Korea, Republic of
University Hospital, Angers

Unknown

Trial of Cyclosporine in the Acute Phase of Leber Hereditary Optic Neuropathy (CICLO-NOHL)

Leber Hereditary Optic Neuropathy

France
Sirion Therapeutics, Inc.

Completed

Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)

Dry Eye Syndromes

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine

Anemia | Thrombocytopenia | Neutropenia | Leukemia, T-Cell | Lymphocytosis

United States
Alexandria University

Recruiting

Effect of Obesity on Cyclosporine Blood Trough Level in Nephrotic Syndrome Patients

Nephrotic Syndrome

Egypt
Tampere University Hospital

Completed

Long-term Outcome of Patients With Acute Ulcerative Colitis After First Course of Intravenous Corticosteroids

Ulcerative Colitis
Sirion Therapeutics, Inc.

Completed

Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)

Dry Eye Syndromes

United States
Hospices Civils de Lyon

Withdrawn

Cyclosporine in Acute Myocardial Infarction Complicated by Cardiogenic Shock (CLOTILDE)

Acute Myocardial Infarction

France
Medical University of Vienna

Completed

The Vienna Prograf and Endothelial Progenitor Cell Study

End Stage Renal Disease

Austria
The Cleveland Clinic

Completed

Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action (CIC)

Interstitial Cystitis

United States
Stanford University

Completed

Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)

Diabetes Mellitus, Type 2 | Diabetic Nephropathy | Kidney Transplant

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple Myeloma

United States, Italy
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute...

Completed

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent... and other conditions

United States, Italy
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome

Mycosis Fungoides | Sezary Syndrome

United States
University of Pittsburgh

Completed

A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen

Sickle Cell Disease | Hemoglobinopathies | Thalassemia

United States
Xiaofan Zhu

Unknown

Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia

Aplastic Anemia

China
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia

Severe Aplastic Anemia

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma

United States
Singapore General Hospital
Translational Immunology Institute

Recruiting

Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis

Plaque Psoriasis

Singapore
University of Alabama at Birmingham

Completed

Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens Wearers

Contact Lens Wearers With Dry Eye Syndrome

United States
Innovative Medical

Completed

Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia

Pterygia

United States
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis (CYSIF)

Ulcerative Colitis | Steroid Refractory

France, Spain, Belgium, Finland, Italy
Novartis

Completed

Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients

Liver Transplant
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus

Graft vs Host Disease | Kidney Failure

Brazil, Mexico

Search clinical trials for: Ciclosporine A

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations